Net profit of Syncom Formulations (India) rose 70.66% to Rs 11.11 crore in the quarter ended September 2024 as against Rs 6.51 crore during the previous quarter ended September 2023. Sales rose 60.26% to Rs 102.31 crore in the quarter ended September 2024 as against Rs 63.84 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales102.3163.84 60 OPM %11.8910.03 - PBDT16.159.33 73 PBT14.858.45 76 NP11.116.51 71 Powered by Capital Market - Live News

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 11 November 2024Powered by Capital Market - Live News

Syncom Formulations (India) announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News

Syncom Formulations (India) announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News

Net profit of Syncom Formulations (India) rose 73.41% to Rs 7.63 crore in the quarter ended June 2024 as against Rs 4.40 crore during the previous quarter ended June 2023. Sales rose 45.82% to Rs 87.26 crore in the quarter ended June 2024 as against Rs 59.84 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales87.2659.84 46 OPM %11.9810.80 - PBDT11.407.21 58 PBT10.106.11 65 NP7.634.40 73 Powered by Capital Market - Live News